Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation
2 other identifiers
observational
36
1 country
1
Brief Summary
The investigators hypothesize that ultrasonography of the newborn lung can be used as an effective diagnostic tool in neonates ≥ 28 weeks gestation with early symptoms of respiratory distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 20, 2012
CompletedFirst Posted
Study publicly available on registry
January 25, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMarch 25, 2016
March 1, 2016
1.7 years
January 20, 2012
March 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
lung ultrasound
The primary endpoint is to determine whether lung ultrasound is comparable or superior to chest radiography: (1) in making the diagnosis of RDS and TTN and (2) in differentiating between RDS and TTN. Disease-specific lung ultrasound findings: (1) Double lung point in TTN and (2) lung white-out in RDS.
within first 24 hours of life.
Study Arms (2)
Respiratory Distress Group
Neonates 28 weeks GA or greater with respiratory distress
Control Group
Neonates 28 weeks GA or greater without respiratory distress.
Interventions
Diagnostic lung ultrasound.
Eligibility Criteria
Neonatal patients admitted to Mount Sinai NICU of gestational age greater than or equal to 28 weeks.
You may qualify if:
- gestational age ≥ 28 weeks
- symptoms of respiratory distress defined as:
- tachypnea (respiratory rate \> 60 breaths per minute)
- FiO2 requirement \>21%
- intercostal/subcostal retractions
- grunting and/or nasal flaring
- If clinically warranted, a chest x-ray will be done as part of the workup for respiratory distress; these patients with CXR will be included in the study.
You may not qualify if:
- neonates with prenatally diagnosed structural cardiac disease
- major multiple congenital anomalies
- other causes of respiratory distress that are not RDS or TTN (e.g. pneumothorax, CCAM or pneumonia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian Holzman, MD
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2012
First Posted
January 25, 2012
Study Start
October 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
March 25, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share